Abstract
Injection of Legionella pneumophila antigen, either killed vaccine or soluble sonicate thereof, resulted in an enhanced antibody response by mouse spleen cells to sheep erythrocytes as determined by the hemolytic plaque assay. Enhancement was dose dependent and reached a peak response at a concentration of 10(7) bacteria or 50 micrograms of sonicate per animal. Larger doses of antigen were less stimulatory or even depressed the antibody response. Similar enhancement of antibody formation by normal spleen cell cultures to sheep erythrocytes in vitro occurred in the presence of graded amounts of L. pneumophila vaccine or sonicate. In addition, the L. pneumophila antigen stimulated enhanced background antibody formation in vitro in the absence of sheep erythrocytes or specific antigen. It appeared likely that the immunoenhancing activity of the L. pneumophila extract may be unrelated to the presence of lipopolysaccharide since boiling the antigen preparation eliminated much of the antibody-enhancing properties of the extract. A large-molecular-weight surface component from L. pneumophila was also immunomodulatory in vitro. Immunostimulation appeared to be related to effects on macrophages since adherent spleen cell populations rich in macrophages, when derived from spleen cell suspensions incubated with L. pneumophila antigen in vitro, stimulated enhanced antibody formation by normal mouse spleen cells in coculture experiments. Further investigations concerning the mechanism of immunomodulation by L. pneumophila antigen in vivo and in vitro appear to be warranted.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Butler R. C., Frier J. M., Chapekar M. S., Graham M. O., Friedman H. Role of antibody response helper factors in immunosuppressive effects of friend leukemia virus. Infect Immun. 1983 Mar;39(3):1260–1264. doi: 10.1128/iai.39.3.1260-1264.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chandler F. W., Hicklin M. D., Blackmon J. A. Demonstration of the agent of Legionnaires' disease in tissue. N Engl J Med. 1977 Dec 1;297(22):1218–1220. doi: 10.1056/NEJM197712012972206. [DOI] [PubMed] [Google Scholar]
- Elliott J. A., Johnson W. Immunological and biochemical relationships among flagella isolated from Legionella pneumophila serogroups 1, 2, and 3. Infect Immun. 1981 Aug;33(2):602–610. doi: 10.1128/iai.33.2.602-610.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Friedman H., Widen R., Lee I., Klein T. Cellular immunity to Legionella pneumophila in guinea pigs assessed by direct and indirect migration inhibition reactions in vitro. Infect Immun. 1983 Sep;41(3):1132–1137. doi: 10.1128/iai.41.3.1132-1137.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Horwitz M. A., Silverstein S. C. Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes. J Clin Invest. 1980 Sep;66(3):441–450. doi: 10.1172/JCI109874. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Johnson W., Elliott J. A., Helms C. M., Renner E. D. A high molecular weight antigen in Legionnaires' disease bacterium: isolation and partial characterization. Ann Intern Med. 1979 Apr;90(4):638–641. doi: 10.7326/0003-4819-90-4-638. [DOI] [PubMed] [Google Scholar]
- Kamo I., Pan S. H., Friedman H. A simplified procedure for in vitro immunization of dispersed spleen cell cultures. J Immunol Methods. 1976;11(1):55–62. doi: 10.1016/0022-1759(76)90018-1. [DOI] [PubMed] [Google Scholar]
- Wong K. H., Moss C. W., Hochstein D. H., Arko R. J., Schalla W. O. "Endotoxicity" of the Legionnaires' disease bacterium. Ann Intern Med. 1979 Apr;90(4):624–627. doi: 10.7326/0003-4819-90-4-624. [DOI] [PubMed] [Google Scholar]